Fournier Ninon, Fabre Alexandre
APHM, Timone Enfant, Pediatric Multidisciplinary Department, Marseille, France.
Aix-Marseille Université, INSERM, GMGF, Marseille, France.
Intractable Rare Dis Res. 2022 Aug;11(3):113-119. doi: 10.5582/irdr.2022.01060.
Smooth muscle disorders affecting both the intestine and the bladder have been known for a decade. However, the recent discovery of genes associated with these dysfunctions has led to the description of several clinical phenotypes. We performed a systematic review of all published cases involving seven genes with pathogenic variants, , , , , , and , and included 28 articles describing 112 patients and 5 pregnancies terminated before birth. The most commonly described mutations involved (75/112, 67% of patients), (14%) and (13%). Twenty-seven patients (28%) died at a median age of 14.5 months. Among the 76 patients for whom this information was available, 10 (13%) had isolated chronic intestinal pseudo-obstruction (CIPO), 17 (22%) had isolated megacystis, and 48 (63%) had combined CIPO and megacystis. The respective proportions of these phenotypes were 9%, 20% and 71% among the 56 patients with mutations, 20%, 20% and 60% among the 10 patients with mutations and 50%, 50% and 0% among the 7 patients with mutations.
影响肠道和膀胱的平滑肌疾病已为人所知达十年之久。然而,最近与这些功能障碍相关基因的发现导致了几种临床表型的描述。我们对所有已发表的涉及7个具有致病变异基因( 、 、 、 、 、 和 )的病例进行了系统综述,纳入了28篇描述112例患者以及5例产前终止妊娠的文章。最常描述的突变涉及 (75/112,占患者的67%)、 (14%)和 (13%)。27例患者(28%)在中位年龄14.5个月时死亡。在可获取此信息的76例患者中,10例(13%)患有孤立性慢性肠道假性梗阻(CIPO),17例(22%)患有孤立性巨膀胱,48例(63%)患有CIPO合并巨膀胱。在56例有 突变的患者中,这些表型的各自比例分别为9%、20%和71%;在10例有 突变的患者中分别为20%、20%和60%;在7例有 突变的患者中分别为50%、50%和0%。